ArticleJournal of clinical medicine2025
Long-Term Cardiorenal Benefits of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Type 2 Diabetes Mellitus: A Real-World Single-Center Experience.
Adnan Agha et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.